Emerging properties of cannabinoid medicines in management of multiple sclerosis.
Use of cannabis as a medicine for numerous conditions has a well-documented history stretching back thousands of years. With the identification of an endogenous system of receptors and ligands in recent years, abundant experimental data have reinforced the anecdotal claims of people who perceive medicinal benefit from the currently illegal consumption of cannabis. This, combined with data from recent clinical trials, points to the prospect of cannabis as a medication in the treatment of multiple sclerosis and numerous other medical conditions.
Pryce
Gareth
G
Department of Neuroinflammation, Institute of Neurology, University College London, 1 Wakefield Street, London, WC1N 1PJ, UK. g.pryce@ion.ucl.ac.uk
Baker
David
D
D000818:Animals; D002186:Cannabinoids / Q000378:metabolism / Q000627:therapeutic use*; D019468:Disease Management; D006801:Humans; D009103:Multiple Sclerosis / Q000188:drug therapy* / Q000378:metabolism; D043882:Receptors, Cannabinoid / Q000378:metabolism
D002186:Cannabinoids; D043882:Receptors, Cannabinoid